Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3529]

Novel Oncology Therapies Presented at Genesis 2010

Novel Oncology Therapies Presented at Genesis 2010

ASH 2010: The German CLL Study Group investigate chlorambucil and GA101 in patients with chronic lymphocytic leukaemia

ASH 2010: The German CLL Study Group investigate chlorambucil and GA101 in patients with chronic lymphocytic...

$ASH: Ofatumumab offer hope for patients with fludarabine-refractory chronic lymphocytic leukaemia$

ASH: Ofatumumab offer hope for patients with fludarabine-refractory chronic lymphocytic leukaemia

ASH 2010: Rituximab after allogeneic stem cell transplantation prevents chronic graft-versus-host disease

ASH 2010: Rituximab after allogeneic stem cell transplantation prevents chronic graft-versus-host disease

Mechanisms of resistance to the melanoma drug PLX4032 uncovered

Mechanisms of resistance to the melanoma drug PLX4032 uncovered

Selective expression of the follicle-stimulating hormone receptor on the surface of tumour blood vessels

Selective expression of the follicle-stimulating hormone receptor on the surface of tumour blood vessels

What we are reading this week at the European Institute of Oncology

What we are reading this week at the European Institute of Oncology

Romiplostim more effective than standard care for immune thrombocytopenia

Romiplostim more effective than standard care for immune thrombocytopenia

SHIP protein identified as a B cell tumour suppressor

SHIP protein identified as a B cell tumour suppressor

ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer

ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer

More from ecancer